The Victorian Government in Australia is set to provide $20m in funding for supporting research to develop treatments to combat cancer.
The funding is from the Victorian Cancer Agency and will be shared among 29 research projects to help improve the quality of life of cancer patients.
Minister for Health Jill Hennessy said: "Investment in cancer research means advances in treatments and a better chance of survival for patients, and one day finding a cure."
The projects will focus on blood, breast, bowel, head and neck, lung, melanoma, oesophageal, ovarian, pancreatic and prostate cancers.
Peter MacCallum Cancer Centre, Swinburne University, the University of Melbourne, University of Toronto, University of Sydney, University of Technology Sydney, Royal Melbourne Hospital and University of Cambridge are among the recipients who will receive the highest amount of funding.
The Labour government is offering $2m to plan and develop a National Centre for Proton Beam Therapy, as well as $25m to develop a state-wide genomic sequencing programme, as part of its investment in cancer prevention.
Hennessy further added: "Whether it’s through the latest medical research, new and innovative technology, or world-first clinical trials, the Labour Government is investing to provide better support and treatment for Victorian cancer patients, and their families."
"Improved cancer survival rates are testament to the ground breaking work of our internationally-renowned cancer experts and our ongoing investment in cancer prevention, research and treatment."
Since being established by the former Labour Government in 2006, the Victorian Cancer Agency has invested $150m into translational cancer research.
Translational research is designed to accelerate the conversion of cancer research findings into clinical practise and new treatments.
In 2014 alone, nearly 30,585 people in Victoria were diagnosed with cancer and 10,744 died from the disease, the government said citing recent data.
The five-year survival rate for Victorians diagnosed with cancer is now 67% compared to 60% five years ago.
Image: Micrograph showing a lymph node invaded by ductal breast carcinoma. Photo: courtesy of Nephron.